Harpoon Therapeutics Stock Gross Profit
Harpoon Therapeutics fundamentals help investors to digest information that contributes to Harpoon Therapeutics' financial success or failures. It also enables traders to predict the movement of Harpoon Stock. The fundamental analysis module provides a way to measure Harpoon Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harpoon Therapeutics stock.
Harpoon |
Harpoon Therapeutics Company Gross Profit Analysis
Harpoon Therapeutics' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Harpoon Therapeutics Gross Profit | (49.48 M) |
Most of Harpoon Therapeutics' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harpoon Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Harpoon Therapeutics reported (49.48 Million) of gross profit. This is 102.21% lower than that of the Biotechnology sector and 105.2% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.18% higher than that of the company.
Harpoon Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Harpoon Therapeutics' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Harpoon Therapeutics could also be used in its relative valuation, which is a method of valuing Harpoon Therapeutics by comparing valuation metrics of similar companies.Harpoon Therapeutics is currently under evaluation in gross profit category among its peers.
Harpoon Fundamentals
| Return On Equity | -2.84 | |||
| Return On Asset | -0.36 | |||
| Profit Margin | (0.82) % | |||
| Operating Margin | (2.73) % | |||
| Current Valuation | 475.25 M | |||
| Shares Outstanding | 21.4 M | |||
| Shares Owned By Insiders | 0.34 % | |||
| Shares Owned By Institutions | 82.85 % | |||
| Number Of Shares Shorted | 1.16 M | |||
| Price To Earning | (5.61) X | |||
| Price To Book | 108.42 X | |||
| Price To Sales | 13.19 X | |||
| Revenue | 37.34 M | |||
| Gross Profit | (49.48 M) | |||
| EBITDA | (35.45 M) | |||
| Net Income | (30.5 M) | |||
| Cash And Equivalents | 90.15 M | |||
| Cash Per Share | 2.72 X | |||
| Total Debt | 16.01 M | |||
| Debt To Equity | 0.43 % | |||
| Current Ratio | 1.62 X | |||
| Book Value Per Share | 1.10 X | |||
| Cash Flow From Operations | (69.38 M) | |||
| Short Ratio | 0.37 X | |||
| Earnings Per Share | (8.62) X | |||
| Target Price | 23.67 | |||
| Number Of Employees | 53 | |||
| Beta | 2.1 | |||
| Market Capitalization | 492.35 M | |||
| Total Asset | 73.73 M | |||
| Retained Earnings | (352.52 M) | |||
| Working Capital | 2.29 M | |||
| Current Asset | 119.62 M | |||
| Current Liabilities | 18.4 M | |||
| Z Score | 10.72 | |||
| Net Asset | 73.73 M |
Pair Trading with Harpoon Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Harpoon Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harpoon Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Williams Companies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Williams Companies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Williams Companies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Williams Companies to buy it.
The correlation of Williams Companies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Williams Companies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Williams Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Williams Companies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Harpoon Stock
If you are still planning to invest in Harpoon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Harpoon Therapeutics' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |